JPMorgan Chase & Co. Increases Stock Holdings in Prelude Therapeutics Incorporated (NASDAQ:PRLD)
JPMorgan Chase & Co. grew its holdings in shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) by 925.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 61,149 shares of the company’s stock after purchasing an additional 55,183 shares during the quarter. JPMorgan Chase & Co.’s holdings in Prelude Therapeutics were worth $78,000 […]
JPMorgan Chase & Co. grew its holdings in shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) by 925.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 61,149 shares of the company’s stock after purchasing an additional 55,183 shares during the quarter. JPMorgan Chase & Co.’s holdings in Prelude Therapeutics were worth $78,000 […]
